Objective To evaluate the clinical features, risk factors and treatment outcomes of endogenous candida albicans endophthalmitis. Methods The clinical data of 11 patients (18 eyes) with vitreous specimen culture-proven endogenous candida endophthalmitis were retrospective reviewed, including risk factors, clinical features and therapeutic methods and outcomes. Results There were 4 males and 7 females patients, aged from 19 to 72 years with a mean age of （41.61plusmn;9.76）years. Seven patients had bilateral endophthalmitis. They had histories of induced abortion (2 patients), intravenous transfusion (3 patients), colon cancer surgery (1 patient), chemotherapy after surgery of malignant lymphoma of colon (1 patient), renal transplantation (1 patient), acute necrotic pancreatitis surgery (1 patient) and diabetes (1 patient). One patient has no special medical history. All patients had no history of ocular trauma or intraocular surgery. The major complaints included blurred vision, metamorphopsia and floaters. It taken an average of (15.23plusmn;8.70) days (3-38 days) for patients to go to the hospital after getting those symptoms. The main clinical manifestations included pre- or sub-retinal white exudates and vitreous inflammations.In 18 eyes, 11 received vitreous surgery, and the other 7 were treated by intravitreal administration of anti-fungal drugs. Ten patients also underwent systemic anti-fungal therapy. The candida endophthalmitis was cured for 10/11 patients and most of them with increased visual acuity. Conclusions Endogenous candida albicans endophthalmitis is characterized by pre- or sub-retinal white exudates and vitreous inflammations. Non-standard intravenous transfusion, induced abortion and malignancy are its major risk factors. Pars plana vitrectomy or intravitreal delivery of anti-fungal drugs can cure this disease.